|
|
|
|
|
|
by anigbrowl
834 days ago
|
|
|
MindMed’s MM120 is set to compete with such drugs as Spravato, a type of ketamine that, for now, is the only FDA-approved nasal spray for treatment-resistant depression. When Spravato came to market in 2019, its manufacturer Johnson & Johnson charged $4,720 to $6,785 per dose. These prices are ridiculous. |
|
|
The first and the best, synthetic dissociative discovered to be an analog of Ketamine, called "Methoxetamine" / MXE, has since been made illegal (shame, it is a euphoric, warm, bladder-safe, highly coveted and respected chemical, RIP); there has been 3-4 generational iterations in the immediate field that yield similar affects - especially the lingering narco-metabolites that leaves the user with the "warm afterglow" after a single dose, which is the mechanism of action for it's remarkable, immediate, and 2-week lasting of it's depression-treating behavior.
Their legality (grey) is dubious but so is the Federal Analog Act.
They are also extremely cheap and relatively easy to find, often on the clearnet/"research chem" communities and purchasable with a credit/debit card.
Their safety profile is well understood - the only common issue is the short "manic" phase some report, but that is nearly exclusive to classic PCP.
>>We hold these truths to be self-evident, that all men are created equal, that they are endowed, by their Creator, with certain unalienable rights, that among these are life, liberty, and the pursuit of property[happiness].